Previous studies have demonstrated that leptin deficiency as well as the pharmacologic blockade of the leptin receptor attenuate disease severity in mouse models of colitis6,7, highlighting a potential role for leptin in inflammatory bowel diseases. This evidence concerns the gene LEPR and inflammatory bowel disease.